CDK inhibitors
US-9499564-B2 · Nov 22, 2016 · US
CDK inhibitors
US10189850B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10189850-B2 |
| Application number | US-201815918852-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2018 |
| Priority date | Oct 25, 2010 |
| Publication date | Jan 29, 2019 |
| Grant date | Jan 29, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of the compound of the structure: wherein the pharmaceutical composition is in the form of a liquid dosage form.
Assignees
Inventors
Classifications
- C07D487/14Primary
Ortho-condensed systems · CPC title
Spiro-condensed pyrazines or piperazines · CPC title
Ortho-condensed systems · CPC title
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title
Spiro-condensed systems · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10189850B2 cover?
- Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
- Who is the assignee on this patent?
- G1 Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D487/14. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).